EurekaMag.com logo
+ Site Statistics
References:
52,725,316
Abstracts:
28,411,598
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Recent progress in the treatment of hematological malignancies. II. Acute lymphoblastic leukemia (ALL)






Nihon Naika Gakkai Zasshi. Journal of the Japanese Society of Internal Medicine 78(6): 769-773

Recent progress in the treatment of hematological malignancies. II. Acute lymphoblastic leukemia (ALL)



Accession: 041185541

PMID: 2794658



Related references

Kimura, K.; Yamada, K., 1989: Recent progress in the treatment of hematological malignancies II. Acute nonlymphocytic leukemia in adult. Nihon Naika Gakkai Zasshi. Journal of the Japanese Society of Internal Medicine 78(6): 765-768

Masaoka, T., 1989: Recent progress in the treatment of hematological malignancies. III. Acute leukemia--bone marrow transplantation. Nihon Naika Gakkai Zasshi. Journal of the Japanese Society of Internal Medicine 78(6): 789-791

Urushizaki, I.; Takaku, F., 1989: Recent progress in the treatment of hematological malignancies. III. Acute leukemia--treatment with cytokines. Nihon Naika Gakkai Zasshi. Journal of the Japanese Society of Internal Medicine 78(6): 781-784

Takenaka, K.; Akashi, K., 2011: Lymphoid malignancies: progress in diagnosis and treatment. Topics: I. Pathogenesis and pathophysiology--recent findings; 1. Leukemia stem cells in acute lymphoblastic leukemia. Nihon Naika Gakkai Zasshi. Journal of the Japanese Society of Internal Medicine 100(7): 1753-1764

Ohshima, T., 1989: Recent progress in the treatment of hematological malignancies. II. Chemotherapy of relapsed and refractory acute myeloid leukemia in adult. Nihon Naika Gakkai Zasshi. Journal of the Japanese Society of Internal Medicine 78(6): 774-780

Pegram, H.J.; Smith, E.L.; Rafiq, S.; Brentjens, R.J., 2016: CAR therapy for hematological cancers: can success seen in the treatment of B-cell acute lymphoblastic leukemia be applied to other hematological malignancies?. Chimeric antigen receptor (CAR) T-cell therapy has recently come into the spotlight due to impressive results in patients with B-cell acute lymphoblastic leukemia. By targeting CD19, a marker expressed most B-cell tumors, as well as normal B cells...

Nagi, K.; Kamada, N., 1989: Recent progress in the treatment of hematological malignancies. IV. Chronic myelocytic leukemia. Nihon Naika Gakkai Zasshi. Journal of the Japanese Society of Internal Medicine 78(6): 792-795

Usui, N., 2011: Lymphoid malignancies: Progress in diagnosis and treatment. Topics: III. Diagnosis and treatment; 1. Management of acute lymphoblastic leukemia and chronic lymphocytic leukemia. Nihon Naika Gakkai Zasshi. Journal of the Japanese Society of Internal Medicine 100(7): 1817-1824

Tomizawa, D., 2015: Recent progress in the treatment of infant acute lymphoblastic leukemia. Treatment of infants with acute lymphoblastic leukemia (ALL), especially those with mixed lineage leukemia (MLL) rearrangement (MLL-r), which account for approximately 80% of cases, is still a major challenge for pediatric hematologists and oncolo...

Jeha, S., 2010: Recent progress in the treatment of acute lymphoblastic leukemia: clofarabine. Significant progress in the treatment of acute lymphoblastic leukemia (ALL) has been achieved through more effective use of established drugs in risk-adapted treatment regimens. As we are reaching the limits of optimizing current treatment strateg...